Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank21
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Latest
$-3.64M
↓ 126% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-1.61M
Historical baseline
PeriodValueYoY Change
2025$-3.64M+37.5%
2024$-5.83M-26.7%
2023$-4.60M-52.2%
2022$-3.02M+37.2%
2021$-4.81M-524.3%
2020$-771000.00-135.1%
2019$2.20M-0.3%
2018$2.20M+35.7%
2017$1.62M+209.3%
2016$525000.00-